ABT-202

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ABT-202
ABT-202 structure.png
Systematic (IUPAC) name
(3S)-1-(pyridin-3-yl)pyrrolidin-3-amine
Clinical data
Legal status
?
Identifiers
ATC code ?
PubChem CID 39220800
ChemSpider 16397614 YesY
Chemical data
Formula C9H13N3 
Mol. mass 163.219
 YesY (what is this?)  (verify)

ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2]

References[edit]

  1. ^ Jain, K. K. (2004). "Modulators of nicotinic acetylcholine receptors as analgesics". Current opinion in investigational drugs (London, England : 2000) 5 (1): 76–81. PMID 14983978.  edit
  2. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.  edit